Comparing Ditropan vs VESIcare
| Ditropan (oxybutynin) | VESIcare (solifenacin) |
|
|---|
| Ditropan (oxybutynin) | VESIcare (solifenacin) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Dysuria, Urinary Incontinence, Urinary Frequency. Ditropan may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Overactive Bladder, Urinary Frequency, Urinary Incontinence. VESIcare may also be used for purposes not listed in this medication guide. |
Related suggestions Urinary Frequency
Urinary Incontinence
|
|||||||
| More about Ditropan (oxybutynin) | More about VESIcare (solifenacin) | ||||||||
| Ratings & Reviews | |||||||||
|
Ditropan has an average rating of 4.7 out of 10 from a total of 34 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 41% reported a negative effect. |
VESIcare has an average rating of 5.6 out of 10 from a total of 144 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 35% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Ditropan side effects |
View all VESIcare side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Lower cost generic approved | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all VESIcare prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Other oxybutynin brands include: Oxytrol, Oxytrol for Women | Other solifenacin brands include: VESIcare LS | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
2.3 hours |
68 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 288 drugs are known to interact with Ditropan:
|
A total of 499 drugs are known to interact with VESIcare:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
July 16, 1975 |
November 19, 2004 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.